Ubs Group Ag Regencell Bioscience Holdings LTD Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
A detailed history of Ubs Group Ag transactions in Regencell Bioscience Holdings LTD stock. As of the latest transaction made, Ubs Group Ag holds 17,876 shares of RGC stock, worth $91,525. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,876
Previous 312
5629.49%
Holding current value
$91,525
Previous $1,000
9800.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding RGC
# of Institutions
3Shares Held
18.1KCall Options Held
0Put Options Held
0About Regencell Bioscience Holdings Ltd
- Ticker RGC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,012,900
- Market Cap $66.6M
- Description
- Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated...